NeuroStar Advanced Therapy Receives Patient Impact Award from Life Sciences PA
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently announced that it has been named a recipient of Life Sciences Pennsylvania’s (LSPA) annual Patient Impact Award for 2022.
NeuroStar Advanced Therapy Receives Patient Impact Award from Life Sciences PA Read More